NCT01373528View on ClinicalTrials.gov

Impact of Topical Sinonasal Budesonide Irrigation on Hypothalamic-Pituitary-Adrenal Axis Function

NATerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Chronic Rhinosinusitis
Interventions
DRUG

Budesonide irrigation

A budesonide (1 mg) in saline (240 mL) irrigation solution is applied to the sinonasal cavities twice daily. 120 mL of the solution is applied via irrigation in the AM, and 120 mL again in the PM.

Trial Locations (1)

K1H 4E9

Ottawa Hospital Riverside Campus, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER